Synergistic effect of zoledronate and compressive force suppresses proliferation and differentiation of human gingival fibroblasts

Br J Oral Maxillofac Surg. 2024 Jan;62(1):63-70. doi: 10.1016/j.bjoms.2023.10.018. Epub 2023 Nov 3.

Abstract

We investigated the effects of zoledronate (ZA) and compressive force, separately and in combination, on the proliferation and differentiation of human gingival fibroblasts (HGFs) to verify the mechanism underlying medication-related osteonecrosis of the jaw (MRONJ). The addition of 100 µM ZA markedly inhibited cell proliferation. Expression of type I collagen, fibroblast growth factor 2, and connective tissue growth factor genes, was decreased by ZA and compressive force. Similar results were observed for collagen expression by using Sirius red staining. These results, together with clinical findings that MRONJ is more common in cases with excessive mechanical stress on the oral mucosa, suggest that bisphosphonates such as ZA and mechanical stress may act in conjunction as risk factors for the development of MRONJ by affecting homeostasis of the oral mucosal tissues, including HGFs.

Keywords: Bisphosphonate; Compressive force; Human gingival fibroblast; Medication-related osteonecrosis of the jaw.

MeSH terms

  • Bisphosphonate-Associated Osteonecrosis of the Jaw*
  • Bone Density Conservation Agents* / adverse effects
  • Cell Proliferation
  • Diphosphonates / adverse effects
  • Fibroblasts / metabolism
  • Gingiva
  • Humans
  • Zoledronic Acid / metabolism
  • Zoledronic Acid / pharmacology

Substances

  • Zoledronic Acid
  • Diphosphonates
  • Bone Density Conservation Agents